Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " April 03, 2013":" May 03, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 03, 2013":" May 03, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection
Condition: HIV
Intervention:
2 Recruiting RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients
Condition: Chronic Infection With HIV
Interventions: Drug: Ritonavir boosted Atazanavir;   Drug: Raltegravir;   Drug: TDF/FTC (or 3TC)
3 Enrolling by invitation The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Condition: HIV Infection
Intervention: Other: Self-Collected HPV Test
4 Completed Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection
Condition: HIV
Interventions: Dietary Supplement: Prebiotics+Glutamine;   Dietary Supplement: Placebo
5 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
6 Unknown  Immune Activation and Drug Absorption in HIV-Infected Patients
Condition: HIV Infection
Intervention: Drug: Rifampicin 600 mg
7 Recruiting Lactoferrin Treatment in HIV Patients
Condition: HIV Infection
Interventions: Drug: Recombinant Lactoferrin;   Drug: Placebo
8 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
9 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
10 Recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
11 Completed Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
12 Completed
Has Results
Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
Condition: HIV-associated Enteropathy
Interventions: Other: Serum-derived bovine immunoglobulin protein isolate (SBI);   Other: Placebo
13 Completed Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
Condition: HIV
Intervention: Device: PrePex
14 Withdrawn SCOPE: Strategies to Combine PrEP With Prevention Efforts
Condition: HIV
Intervention: Drug: Once daily Truvada®
15 Completed HCV Treatment in HIV Co-Infected Patients in Asia
Conditions: Hepatitis C;   HIV
Intervention: Drug: Pegylated-Interferon and Ribavirin
16 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
17 Completed An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Condition: HIV-associated Lipodystrophy Syndrome
Interventions: Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B;   Drug: 150 mg GSK1265744B;   Drug: Placebo
18 Completed Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV
Condition: HIV
Intervention: Behavioral: Aerobic and Strength Training Intervention
19 Recruiting Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
Condition: HIV
Interventions: Biological: pSG2.HIVconsv DNA vaccine;   Biological: ChAdV63.HIVconsv booster vaccine;   Biological: MVA.HIVconsv booster vaccine;   Drug: CPHPC;   Other: Placebo
20 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.